1. Fernandes Garcia MV, Lahm T.
   HIV-associated pulmonary arterial hypertension: improving survival despite persistent treatment gaps - a systematic review and meta-analysis.
   AIDS 2026;40:1773-1776.
   


2. Clemente T, Capra N, Malagnino V, Lolatto R, et al.
   Real-life durability and virological outcomes of doravirine in people with multidrug-resistant HIV.
   AIDS 2026;40:1769-1773.
   


3. Kasprowicz VO, Deeks SG, Kilembe W, Dong KL, et al.
   An inclusive approach for developing global clinical trial recommendations.
   AIDS 2026;40:1765-1768.
   


4. Vera JH.
   Cognitive trajectories in HIV: looking beyond the virus to preserve brain health.
   AIDS 2026;40:1762-1764.
   


5. de Avila L, AlNaamani KM, Papatheodoridi M, Petta S, et al.
   Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease.
   JAMA 2026.
   


6. Sheira LA, Mlowe M, Katabaro E, Joseph B, et al.
   Missed opportunities for PrEP among the partners of people newly initiated in HIV care in western Tanzania.
   J Acquir Immune Defic Syndr 2026.
   


7. Buccheri R, Spinelli MA, Saberi P, Neilands TB, et al.
   At-Home Point-of-Care Urine Tenofovir Testing for Adherence Monitoring: Feasibility and Comparison with Adherence Metrics in Dried Blood Spots.
   J Acquir Immune Defic Syndr 2026.
   


8. Sim BZ, Steinbrink JM, Miller C, Antonia A, et al.
   The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection.
   J Infect Dis 2026.
   


9. Alkhafaji S, Yang E, Lee K, Chang VK, et al.
   Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis.
   J Infect Dis 2026.
   


10. Hodgson SH, McCarthy JS, Duncan JA, Williams E, et al.
    Expert Consensus on Controlled Human Infection Studies for Gonorrhoea.
    J Infect Dis 2026.
    


11. Poliseno A, Rahangdale L, Schauer A, Sykes C, et al.
    Changes in Doravirine Pharmacokinetics During Pregnancy: A Longitudinal Single Dose Study.
    J Infect Dis 2026.
    


12. Zeng M, Liu D, Zhang J, Zhang L, et al.
    MOV10 inhibits SADS-CoV replication by enhancing TRIM24-mediated K63-linked TRAF3 ubiquitination, and this inhibition is antagonized by viral N protein.
    J Virol 2026.
    


13. Song Y, Xia T, Martin C, Despres G, et al.
    Functional redundancy, complementation, and cross-talk between CH25h and IFITM3 in infection and in IFITM3 trafficking and secretion.
    J Virol 2026.
    


14. Yuan J, Yang W, Xu M, Hu H, et al.
    Deubiquitinase USP8 inhibits HIV-1 replication by suppressing Tat-mediated viral transactivation.
    J Virol 2026.
    


15. Brink N, Butler R, Machingura F, Chersich M, et al.
    Declare the climate crisis a Public Health Emergency of International Concern.
    Lancet 2026.
    


16. Torres-Fernandez D, Fernandez-Luis S, Dominguez-Rodriguez S, Nhampossa T, et al.
    HIV-1 Drug Resistance in Mother-Infant Pairs in Southern Mozambique.
    Pediatr Infect Dis J 2026.
    

Display articles in

• Abstract format